EUVIMEDOpdag EUVIMED
Crossref

Hyperbaric Oxygen Treatment Decreases Cd36 Gene Expression Through HIF-1α/PPAR-γ and Reverses Non-Alcoholic Fatty Liver Disease in Rats

Marcos de J. Reyes Bocanegra, BS, Rodolfo Quintana Castro, PhD, Luis Páez Martínez, BS, Beatriz Agame Lagunes, PhD, Peter Grube Pagola, PhD, Sandra Hernández Leyva, PhD and 4 more

Undersea and Hyperbaric Medicine · 2026-06-28 · 53 (2) · 215-226

DOI: 10.22462/825 ↗

At a glance

Journal article in Undersea and Hyperbaric Medicine, published online on 2026-06-28. Written by Marcos de J. Reyes Bocanegra and 15 co-authors.

AbstractBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Reyes Bocanegra MdJ, Quintana Castro R, Páez Martínez L, Agame Lagunes B, Grube Pagola P, Hernández Leyva S, Ramírez Nava JC, Alexander Aguilera A. Hyperbaric Oxygen Treatment Decreases Cd36 Gene Expression Through HIF-1α/PPAR-γ and Reverses Non-Alcoholic Fatty Liver Disease in Rats. Undersea Hyperb Med. 2026 Second Quarter; 53(2):215-226.

Introduction

Non-alcoholic fatty liver disease (NAFLD) is characterized by the accumulation of liver fat (steatosis), which can progress to non-alcoholic steatohepatitis (NASH), cirrhosis, and cancer. NASH is estimated to affect up to 32% of the world's population. Different treatments, such as hyperbaric oxygen (HBO2), are being investigated, but the molecular mechanisms associated with this treatment are unknown. The effect of HBO2 on NAFLD associated with Cd36 expression was evaluated.

Methods

Rats were divided into the following groups: rats that developed steatosis and consumed sucrose but did not receive HBO2, rats with steatosis that consumed sucrose and received HBO2, rats that developed steatosis and received HBO2 but did not receive sucrose, and a control group. The HBO2 groups underwent the procedure for 20 days (2.4 ATA pressure 60 min). An IYOCA hyperbaric chamber model for rats was used. The expression of HIF-1α, PPAR-γ, and Cd36 mRNA from hepatic tissue was measured with the StepOne™ real-time polymerase chain reaction (PCR) system.

Results

The expression levels of hepatic HIF-1α, PPAR-γ, and Cd36 genes increased in NAFLD rats that consumed sucrose but did not receive HBO2 compared to the control group (p

Cite

APA

Bocanegra, M. D. J. R., BS, Castro, R. Q., PhD, Martínez, L. P., BS, Lagunes, B. A., PhD, Pagola, P. G., PhD, Leyva, S. H., PhD, Nava, J. R., MSc, Aguilera, A. A., & PhD (2026). Hyperbaric Oxygen Treatment Decreases Cd36 Gene Expression Through HIF-1α/PPAR-γ and Reverses Non-Alcoholic Fatty Liver Disease in Rats. Undersea and Hyperbaric Medicine, 53(2), 215-226. https://doi.org/10.22462/825

Vancouver

Bocanegra MDJR, BS, Castro RQ, PhD, Martínez LP, BS, et al. Hyperbaric Oxygen Treatment Decreases Cd36 Gene Expression Through HIF-1α/PPAR-γ and Reverses Non-Alcoholic Fatty Liver Disease in Rats. Undersea and Hyperbaric Medicine. 2026;53(2):215-226. doi:10.22462/825

BibTeX
@article{Bocanegra2026,
  author = {Bocanegra, Marcos de J. Reyes and BS and Castro, Rodolfo Quintana and PhD and Martínez, Luis Páez and BS and Lagunes, Beatriz Agame and PhD and Pagola, Peter Grube and PhD and Leyva, Sandra Hernández and PhD and Nava, Julio Ramírez and MSc and Aguilera, Alfonso Alexander and PhD},
  title = {Hyperbaric Oxygen Treatment Decreases Cd36 Gene Expression Through HIF-1α/PPAR-γ and Reverses Non-Alcoholic Fatty Liver Disease in Rats},
  journal = {Undersea and Hyperbaric Medicine},
  year = {2026},
  volume = {53},
  number = {2},
  pages = {215--226},
  doi = {10.22462/825}
}
Start for free →